marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Arcus Biosciences Financial Ratios 2011-2024 | RCUS
Annual Financial Ratios Arcus Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.9 | -4.9 | 48.6 | -15.7 | -4.7 | -6.6 | - | - | - | - | - | - | - |
P/S |
10.3 | 11.7 | 6.7 | 24.8 | 26.6 | 39.4 | - | - | - | - | - | - | - |
EPS |
-4.2 | -3.7 | 0.8 | -2.2 | -1.9 | -1.4 | -29.0 | -20.8 | - | - | - | - | - |
EV (Enterprise Value) |
1.08 B | 1.1 B | 2.43 B | 1.76 B | 380 M | 298 M | 36.6 M | 10.2 M | - | - | - | - | - |
EBITDA per Share |
-4.49 | -3.81 | 0.84 | -2.21 | -1.94 | -1.48 | - | - | - | - | - | - | - |
EV/EBITDA |
54.5 | -17.0 | -4.0 | -5.0 | - | - | - | - | - | - | - | ||
PEG |
- | 0.4 | 0.02 | -0.04 | - | - | - | - | - | - | - | ||
P/B |
1.1 | 1.0 | 1.6 | 2.5 | 2.4 | 1.4 | - | - | - | - | - | - | - |
P/CF |
-4.0 | 3.0 | -10.1 | 17.4 | -5.3 | -7.0 | - | - | - | - | - | - | - |
ROE % |
-66.45 | -40.64 | 6.29 | -24.50 | -51.70 | -21.11 | - | - | - | - | - | - | - |
ROA % |
-28.04 | -19.85 | 3.33 | -15.93 | -41.71 | -18.04 | - | - | - | - | - | - | - |
ROCE % |
-73.59 | -42.62 | 6.41 | -24.70 | -49.17 | -21.26 | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | 8.5 | 15.3 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 3.2 | 3.6 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Arcus Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1 | -1.02 | -0.05 | - | -0.94 | -1.04 | -1.09 | - | -0.9 | -0.93 | -0.96 | - | -1.11 | -1.09 | -1.08 | -0.82 | 0.03 | -0.93 | -0.63 | - | -0.51 | -0.64 | -0.41 | - | -0.25 | -0.32 | -1.37 | - | -11.86 | -5.64 | -4.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.15 | - | - | - | -1.15 | - | -0.91 | -0.96 | -0.93 | - | -1.08 | -1.09 | -1.07 | - | 0.06 | -0.9 | -0.62 | - | -0.51 | -0.62 | -0.4 | - | -0.25 | -0.34 | -1.08 | - | -5.62 | -2.32 | -1.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-45.15 | -42.52 | -41.12 | -40.24 | -49.54 | -45.18 | -40.90 | -26.80 | -41.17 | -46.24 | -49.84 | -37.86 | -48.18 | -33.45 | -29.85 | -24.46 | -24.27 | -38.27 | -46.44 | -51.70 | -46.80 | -37.76 | -26.38 | -21.11 | 2.39 | 38.96 | 57.92 | 73.39 | 55.13 | 23.16 | 9.95 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-21.46 | -20.07 | -18.38 | -18.49 | -23.15 | -21.85 | -20.11 | -13.47 | -22.77 | -22.99 | -31.44 | -25.51 | -32.22 | -22.69 | -20.08 | -15.91 | -17.37 | -28.61 | -36.60 | -41.71 | -38.01 | -30.93 | -22.03 | -18.04 | -20.50 | -28.71 | -28.80 | -27.87 | -20.93 | -8.79 | -3.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-52.92 | -49.73 | -47.70 | -44.38 | -54.40 | -49.03 | -43.60 | -27.66 | -42.06 | -46.44 | -49.80 | -37.94 | -37.63 | -22.92 | -19.36 | -14.38 | -28.57 | -43.07 | -51.83 | -43.45 | -48.61 | -39.59 | -28.56 | -17.61 | 14.37 | 51.53 | 71.66 | 55.44 | 55.44 | 23.45 | 10.09 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | 2.0 | - | 2.1 | 2.1 | 2.8 | 3.0 | 3.5 | 2.9 | 2.9 | 2.9 | 2.9 | 5.2 | 5.2 | 5.2 | 5.2 | 6.9 | 6.9 | 6.9 | 6.9 | 5.2 | 5.2 | 5.2 | 5.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency